Related Experiment Video

Updated: Mar 26, 2026

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.8K

Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion

M Fruschelli1, L Puccetti, F Bruni

  • 1Department of Ophthalmology and Neurosurgery, Centro per lo Studio delle Malattie Dismetaboliche e della Aterosclerosi, University of Siena, Italy. fruschelli@unisi.it

Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|March 29, 2002
PubMed

Insights

Central retinal vein occlusion (CRVO) is linked to impaired fibrinolysis, a blood clotting process. This fibrinolytic impairment plays a significant role in the development of CRVO, even in patients without metabolic issues.

Area of Science:

  • Ophthalmology
  • Hematology
  • Vascular Medicine

Background:

  • Central retinal vein occlusion (CRVO) is a leading cause of vision impairment.
  • Known risk factors include diabetes mellitus, hypertension, and coagulation disorders.
  • The role of fibrinolytic function in CRVO pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the metabolic, coagulative, and fibrinolytic profiles of patients with CRVO.
  • To identify specific patterns associated with the onset of central retinal vein occlusion.

Main Methods:

  • Study included 54 patients diagnosed with CRVO (26 males, 28 females, mean age 50.4 years).
  • Patients with other ocular conditions were excluded.
  • Assessment of metabolic, coagulative, and fibrinolytic parameters was performed.

Main Results:

  • Fibrinolytic impairment was identified as the most prevalent feature in the studied CRVO population.
  • This impairment was observed in both dysmetabolic and non-metabolic subjects.
  • Coagulative and metabolic patterns were also analyzed in relation to CRVO.

Conclusions:

  • A significant impairment of the fibrinolytic system is a common characteristic in patients with CRVO.
  • These findings highlight the prominent role of fibrinolysis in the pathogenesis of central retinal vein occlusion.
  • Further research into fibrinolytic mechanisms may offer new therapeutic targets for CRVO.

More Related Videos

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

3.3K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

9.5K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
433
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
673
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K